v3.25.4
Restructuring
 12 Months Ended
Dec. 31, 2025
Restructuring and Related Activities [Abstract]  
Restructuring and severance
12.    Restructuring
The following table presents restructuring and severance expenses by plan:
(in millions)
Year ended December 31,
202520242023
2024 restructuring program$(5.3)$82.8 $— 
Other35.1 — 26.5 
Total$29.8 $82.8 $26.5 
Restructuring and severance charges are classified as SG&A expenses or cost of sales depending on the nature of the expense.
2024 restructuring program
The 2024 restructuring program is a part of the Company’s multi-year cost transformation initiative designed to right-size the Company’s cost base and optimize its footprint and organizational structure with a focus on driving cost improvement and productivity. During 2025, we recognized a $(5.3) million non‑cash adjustment that reduced the previously recorded 2024 restructuring accrual, primarily reflecting updates to expected severance and other exit costs that were no longer required. No additional material charges were incurred in 2025, and we do not expect to incur additional material charges related to this program in future periods.
The following table presents information about expenses under the 2024 restructuring program for the periods covered under this report in which the plan was active:
(in millions)Year ended December 31,
As of year ended December 31, 2025
20252024Charges incurredExpected remaining chargesTotal expected charges
Employee severance and related$(5.3)$64.3 $59.0 $— $59.0 
Facility closure— 1.6 1.6 — 1.6 
Other— 16.9 16.9 — 16.9 
Total$(5.3)$82.8 $77.5 $— $77.5 
Laboratory Solutions$(1.7)$41.3 $39.6 $— $39.6 
Bioscience Production (3.6)40.6 37.0 — 37.0 
Corporate— 0.9 0.9 — 0.9 
Total$(5.3)$82.8 $77.5 $— $77.5 
Other charges in the table above primarily relate to the write-downs of the carrying value of assets that we have disposed of under the program.
The following table presents changes to accrued employee severance and related expenses under the 2024 restructuring program, which are primarily classified as employee-related current liabilities:
(in millions)
Year ended December 31,
2025
Beginning balance$21.3 
Non-cash adjustments(5.3)
Cash payments(12.5)
Currency translation(0.6)
Ending balance$2.9